Decheng Capital Global Healthcare Fund (Master), LP, 10% Owner at ALPINE IMMUNE SCIENCES, INC. (ALPN), bought 375,000 shares at $12.50 ($4.7M) on 2023-11-09, disclosed to the SEC on 2023-11-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| CGON | BUY | 2024-01-31 | $7.6M | — | Filing → |